Ge Healthcare South Asia: Wipro GE Healthcare on Tuesday said it will invest over Rs 8,000 crore in India over the next five years to increase local manufacturing and research and development (R&D) initiatives. The company, a leading global medical technology, pharmaceutical diagnostics, and digital solutions provider, said as a part of the investment, its 'Made in India' PET CT Discovery IQ scanner will be exported to 15 countries."
Wipro Ge Healthcare on Tuesday said it will invest over Rs 8000 Crore in India over the next five years to increase local manufacturing , research and development initiatives. The company a leading global medical technology, pharmaceuticals, diagnostic and digital solution provider said as part of the investment, It Made in India PET CT Discovery Iq Scanner will be exported to 15 countries.
Additionally locally produced Revotultion Aspire CT, Revolution Act and MR breast coils will be manufacturing in India for the World: The company said in a statement.
The strategic investment bolsters the company local manufacturing Footprint to addressing the growing domestic and international market. it will also build supply chain resiliency for the Organisation.
Wipro GE Healthcare Chairman Ajay prem Ji said India riding the resurgent growth in the healthcare industry and rapidly expanding Medtech sector
"With Make in India" We are witnessing an exponential expansion of manufacturing footprint in the country, strenghtening India capability as the Medtech hub of the world
Ge Healthcare President and CEO Peter J Arduini said India is a high potential, high priority market for Ge Healthcare Globally.